dipyridamole has been researched along with Erythremia in 9 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| Berliner, S | 1 |
| Shoenfeld, Y | 1 |
| Shaklai, M | 1 |
| Pinkhas, J | 1 |
| Meschengieser, SS | 1 |
| Woods, AI | 1 |
| Schattner, MA | 1 |
| Lazzari, MA | 1 |
| Bertrán, X | 1 |
| Muchart, J | 1 |
| Planas, R | 1 |
| Real, MI | 1 |
| Ribera, JM | 1 |
| Cabré, E | 1 |
| Menacho, M | 1 |
| Gassull, MA | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Callis, M | 1 |
| Indrák, K | 1 |
| Kapustová, M | 1 |
| Hrcková, Y | 1 |
| Kubis, M | 1 |
| Scudla, V | 1 |
| Jezdinský, J | 1 |
| Tartaglia, AP | 1 |
| Goldberg, JD | 1 |
| Berk, PD | 1 |
| Wasserman, LR | 2 |
1 review available for dipyridamole and Erythremia
| Article | Year |
|---|---|
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
8 other studies available for dipyridamole and Erythremia
| Article | Year |
|---|---|
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
Conservative treatment of Budd-Chiari syndrome in polycythemia vera.
Topics: Aspirin; Budd-Chiari Syndrome; Busulfan; Dipyridamole; Female; Furosemide; Humans; Leukapheresis; Mi | 1981 |
[Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Topics: Adult; Aspirin; Blood Platelet Disorders; Dipyridamole; Female; Humans; Leukemia, Myeloid; Male; Mid | 1981 |
Occlusion of the superior mesenteric artery in a patient with polycythemia vera: resolution with percutaneous transluminal angioplasty.
Topics: Angioplasty, Balloon; Dipyridamole; Humans; Male; Mesenteric Artery, Superior; Mesenteric Vascular O | 1996 |
[Ischemic lesions in polycythaemia vera (author's transl)].
Topics: Aspirin; Dipyridamole; Female; Foot; Humans; Ischemia; Male; Middle Aged; Pain; Polycythemia Vera; S | 1977 |
Comparison of the effects of acylpyrin, curantyl and ticlid on some platelet functions in patients with polycythemia vera.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Agg | 1985 |
Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.
Topics: Aspirin; Dipyridamole; Female; Hemorrhage; Humans; Male; Phosphorus Radioisotopes; Platelet Aggregat | 1986 |
A cooperative study of polycythemia vera.
Topics: Aspirin; Chlorambucil; Dipyridamole; Humans; Leukemia; Polycythemia Vera; Prognosis | 1985 |